HIGHLINE WEALTH PARTNERS LLC

Position in PFE — Pfizer Inc

CIK 2042654 SHERMAN OAKS, CA

Position in PFE

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$56,732

-$31,439 QoQ

Shares Held

2,356

-25.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#2,610

of 2,821 holders

Holding Since

Sep 2022

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HIGHLINE WEALTH PARTNERS LLC holds $1,353,065 across 14 Drug Manufacturers - General names. PFE ranks #7 (4.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,635	$415,240
2	LLY	ELI LILLY & Co	180	$215,897
3	AMGN	Amgen Inc	429	$155,349
4	MRK	Merck & Co., Inc.	932	$119,762
5	ABBV	AbbVie Inc.	419	$105,437
6	AZN	Astrazeneca PLC	314	$59,540
7	PFE	Pfizer Inc This page	2,356	$56,732
8	GILD	Gilead Sciences, Inc.	446	$56,347

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$56,732	2,356	-25.0%	Shares	Sole	2026-07-15
2026-03-31	$88,171	3,140	+173.8%	Shares	Sole	2026-04-06
2025-12-31	$28,560	1,147	+18.4%	Shares	Sole	2026-01-15
2025-09-30	$24,690	969	+6.1%	Shares	Sole	2025-10-14
2025-06-30	$22,131	913	-37.6%	Shares	Sole	2025-07-16
2025-03-31	$37,072	1,463	+27.6%	Shares	Sole	2025-04-17
2024-12-31	$30,429	1,147	-97.2%	Shares	Sole	2025-01-10
2024-09-30	$1,174,992	40,601	+2.1%	Shares	Sole	2024-10-25
2024-06-30	$1,113,100	39,782	+3.3%	Shares	Sole	2024-10-28
2024-03-31	$1,068,763	38,514	+1.6%	Shares	Sole	2024-10-28
2023-12-31	$1,091,141	37,900	+7.9%	Shares	Sole	2024-10-29
2023-09-30	$1,165,494	35,137	+0.0%	Shares	Sole	2024-10-29
2023-06-30	$1,288,385	35,125	+0.1%	Shares	Sole	2024-10-29
2023-03-31	$1,431,468	35,085	+2.8%	Shares	Sole	2024-10-29
2022-12-31	$1,748,616	34,126	0.0%	Shares	Sole	2024-10-29
2022-09-30	$1,493,353	34,126	—	Shares	Sole	2024-10-29
No filing history on record for this holder in this stock.